Merck

YTD

ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

CEO

Robert M. Davis

CEORobert M. Davis

Employees

75,000

Employees75,000

Headquarters

Rahway, New Jersey

HeadquartersRahway, New Jersey

Founded

1891

Founded1891

Employees

75,000

Employees75,000

MRK Key Statistics

Market cap

277.98B

Market cap277.98B

Price-Earnings ratio

31.35

Price-Earnings ratio31.35

Dividend yield

2.98%

Dividend yield2.98%

Average volume

7.62M

Average volume7.62M

High today

$112.89

High today$112.89

Low today

$110.97

Low today$110.97

Open price

$111.53

Open price$111.53

Volume

7.87M

Volume7.87M

52 Week high

$125.14

52 Week high$125.14

52 Week low

$74.37

52 Week low$74.37

Stock Snapshot

Merck(MRK) stock is priced at $112.56, giving the company a market capitalization of 277.98B. It carries a P/E multiple of 31.35 and pays a dividend yield of 3.0%.

On 2026-05-18, Merck(MRK) stock moved within a range of $110.97 to $112.89. With shares now at $112.56, the stock is trading +1.4% above its intraday low and -0.3% below the session's peak.

Trading volume for Merck(MRK) stock has reached 7.87M, versus its average volume of 7.62M.

The stock's 52-week range extends from a low of $74.37 to a high of $125.14.

MRK News

Investing.com 1h

Merck raises $6 billion in bond sale to refinance Terns deal - Investing.com

...

TipRanks 9h

Merck’s Sac-TMT met primary endpoints in endometrial cancer trial

Merck (MRK) announced the pivotal Phase 3 TroFuse-005 trial evaluating sacituzumab tirumotecan, or sac-TMT, an investigational TROP2-directed antibody-drug conj...

Simply Wall St 4d

Is Merck Fairly Valued After Strong Long Term Returns And Mixed Intrinsic Value Signals

Advertisement Merck stock performance snapshot and recent context Merck (MRK) trades around $113.45, with the stock roughly flat over the past week and down a...

Analyst ratings

70%

of 30 ratings

Buy

70%

Hold

30%

Sell

More MRK News

The Wall Street Journal 6d

Germany’s Merck KGaA Raises Guidance

Merck KGaA forecast net sales to range from €20.4 billion to €21.4 billion this year, up from of €20 billion to €21.1 billion. Ralph Orlowski / Reuters Germany...

Simply Wall St 6d

Did Merck's Upgraded 2026 Outlook and Keytruda Deals Just Redefine Its Investment Narrative?

In recent weeks, Merck & Co., Inc. reported first-quarter 2026 results with US$16,286 million in sales, a net loss of US$4,240 million driven by acquisition-rel...

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Flowserve

ResMed

SPDR EURO STOXX 50 ETF

Cognex

WisdomTree Japan Hedged E…

Baker Hughes Company

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.